Lifescience Global

Journal of Cancer Research Updates | Volume 2 Number 4

Cancer-Research-UpdatesWEB


Table of Contents

Volume 2 No. 4, 2013

 * This issue includes papers published with Open Access


Gastrointestinal Stromal Tumors Presenting as Surgical Emergencies: A Six-Patient Case Series - Pages 232-236
Fazilet Erozgen, Hüseyin Kadıoğlu, Mehmet Celal Kızılkaya, Muzaffer Akıncı, Ahmet Kocakuşak, Adnan Hut, Mehmet Gülen, Ömer Güngörür and Rafet Kaplan
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.1

Short-Time Outcome of Intraoperative Radiotherapy (IORT): A Study on Side-Effects and Quality of Life in the Treatment of Early Breast Cancer - Pages 237-245
Caroline Page, Pierre-Alain Brioschi and Jacques Bernier
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.2

Open AccessIs FLT3 Internal Tandem Duplication an Unfavorable Risk Factor for High Risk Children with Acute Myeloid Leukemia? – Polish Experience - Pages 246-253
K. Pawinska-Wasikowska, T. Ksiazek, A. Wieczorek, M. Matysiak, B. Fic-Sikorska, E. Adamkiewicz-Drozynska, L. Maciejka-Kapuscinska, A. Chybicka, K. Potocka, J. Wachowiak, J. Skalska-Sadowska, J. Kowalczyk, B. Wojcik, M. Wysocki, S. Koltan, M. Krawczuk-Rybak, K. Muszynska-Roslan, W. Mlynarski, M. Stolarska, T. Urasinski, E. Kamienska, T. Szczepanski, R. Tomaszewska, G. Sobol-Milejska, A. Mizia-Malarz, G. Karolczyk, J. Pohorecka, M. Wieczorek, I. Karpinska-Derda and W. Balwierz
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.3

Open AccessDisease–Free Remission Exceeding 37 Years in Patients Treated as Children for Acute Leukemia (AL) with Immunotherapy Using Viable (Cryopreserved) Allogeneic Leukemic Cells - Pages 254-264
Tatiana I. Bulycheva, Svetlana A. Mayakova and Simon V. Skurkovich
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.4

Open AccessDrug Resistance Mechanisms in Non-Small Cell Lung Carcinoma - Pages 265-282
Janet Wangari-Talbot and Elizabeth Hopper-Borge
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.5

Open AccessWeekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial - Pages 283-288
J.L. Layton, J.F. Renzulli II, A.M. Taber, D. Golijanin, J.E. Collins, H.H. Safran and A.E. Mega
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.6

Open AccessEffects of Nodal Status and Extent of Surgery on Survival in Triple Negative Breast Cancer - Pages 289-296
Raafat S. Alameddine, Nagi S. El Saghir, Elias Elias, Ahmad Saleh, Fady B. Geara, Sally Temraz and Ali Shamseddine
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.7

Open AccessIs the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?
- Pages 297-305
Zeli Huang, Jiezhan Feng, Shaoen Li, Weihong Wei, Guoyi Zhang, Qiuxia Lu, Yongfeng Wu, Li Lin and Tao Xu
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.8

Open AccessVemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance - Pages 306-317
Saurabh G. Vispute, Jun-Jiang Chen, Yue-Li Sun, Kamlesh S. Sodani, Satyakam Singh, Yihang Pan, Tanaji Talele, Charles R. Ashby Jr and Zhe-Sheng Chen
DOI: http://dx.doi.org/10.6000/1929-2279.2013.02.04.9

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn

OUR STRENGTHS

♦  Worldwide readership
♦  High quality content
♦  Maximum visibility
♦  Efficient publishing
♦  Optional Open Access

Publish your Research

Survey

As an author what type of publishing model you prefer?

780
Open Access
493
Optional Open Access
338
Subscription based
5 Votes left